Global Blister Packaging Machine Pharmaceutical Industry Size Likely to Grow at a CAGR of 2.8% By 2034

Market Size and Growth

As per the Blister Packaging Machine Pharmaceutical Industry size analysis conducted by the CMI Team, the global Blister Packaging Machine Pharmaceutical Industry is expected to record a CAGR of 2.8% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 2.57 Billion. By 2034, the valuation is anticipated to reach USD 3.29 Billion.

Overview

As per the industry experts at CMI, Key companies in the Blister Packaging Machine Pharmaceutical Industry are Uhlmann, IMA, Marchesini Group, and Romaco, paying attention to automation, compact modularity, and regulatory compliance with pharmaceutical traceability systems EU FMD and US DSCSA. These companies are creating sophisticated thermoforming and cold-forming systems incorporating vision inspection AI, serialization, and real-time OEE monitoring.

Eco-conscious designs using recyclable packaging films and energy-efficient drives are gaining traction. Collaborations with pharmaceutical R&D units and packaging material innovators are accelerating the development of precise dosing systems, tamper-evident features, and sustainable production lines, all while aligning with evolving GMP and ESG mandates in global pharma markets.

Key Trends & Drivers

• Expanding Opportunity for Unit-Dose and Tamper Evident Parking: In the pharmaceutical industry, especially concerning the elderly and children, there is an increasing demand for unit-dose packaging. Blister packs serve multifunctional roles in dispensing accurate doses, enhancing product shelf life, improving patient compliance to therapy, and providing tamper-evidence and resistance, which assists in regulatory compliance. This increases healthcare provider trust. Due to increasing focus on medication accuracy and safety within healthcare systems, pharmaceutical companies are embracing fast, precise, and compliant solid oral dosage form blister packaging machines, further accelerating market expansion.

• Compliance with the Regulatory Framework of the EU and US: These regulations, like the ‘US drug supply chain security act’ and the ‘EU falsified medicines directive’ bear a significant impact on pharmaceutical packaging to have serial numbers and traceability embedded in them. With global restrictions such as ‘vision systems, coding units, and track and trace software’, the burners of blister packaging machinery are made outright due to these laws. Increased competition is now on the surge. As firms work with more complex regulations, there is a greater need for machines able to interface with IT systems for data collection and verification, leading to more sophisticated blister packing devices.

• Expanding Industry for Blister Packaging Machines: There is now greater demand for flexible and high throughput blister packaging machines due to the rising demand for contract manufacturing organizations (CMOs) and third-party packagers. These service companies require sophisticated and multi-purpose machinery capable of processing a wide range of drugs and packaging materials in an efficient manner. Outsourcing production as a balance of specialization drives competitive pharmaceutical firms that concentrate on core R&D functions, which in turn drives CMOs to invest in fast blister packaging systems that provide speedy changeover and automation in cleanroom environments. This also sustains the global market for blister packaging machines.

Report Scope

SWOT Analysis

• Strengths: The blister packaging equipment guarantees significant protection, prolongs shelf life, and offers accurate unit dose packaging critical for pharmaceutical compliance. Their use in conjunction with serialization and track-and-trace technologies further strengthens compliance. Added automation, a compact perch, and multi-format flexibilities of newer machines improve scalability and operational efficiency to meet demand while maintaining patient safety and contamination risks.

• Weaknesses: Pharmaceutical SMEs encounter difficulties with high initial capital and complex calibration and maintenance systems. A lack of skilled technicians, along with specialized personnel, drives up operational expenditures. In addition, there is considerable time lost on retrofitting, which significantly increases costly modification, leading to slow time-to-market and limited production throughput. In addition to all of this, extensive time is wasted on costly retrofitting, hindering production efficiency, delaying time-to-market, and significantly cutting production throughput. These systems are still too costly to adapt to changing regulatory frameworks and eco-packaging policies.

• Opportunities: Developing markets offer great prospects for packaged unit doses and other forms of tamper evident packaging with expanded demand. Automated blister machines are now more widely accepted because of government policies supporting smart packaging and traceability. Sustainable water-based adhesives and blister films, which provoke concern, are, in fact, a spur to eco-innovation. Collaboration with firms in other digital sectors now allows the infusion of hyperautomation AI and IoT, as well as predictive maintenance, into production lines.

• Threats: Heightened requirements from the FDA and EMA entail more frequent compliance checks, which could lead to expensive compliance costs for small to mid-tier pharma companies due to the need for frequent machinery upgrades. Production may be delayed due to supply chain issues with components, for example, control systems and servo drives. There is also stiff competition from alternative formats of flexible packaging as well as low-cost regional manufacturers of packaging machinery. This further erodes the market share and pricing power of premium branded machines in mature markets.

List of the prominent players in the Blister Packaging Machine Pharmaceutical Industry:

• Uhlmann Group
• IMA Group
• Marchesini Group
• Romaco Group
• Mediseal GmbH
• Hoonga Co. Ltd.
• CAM Packaging Systems
• ACG Pampac (ACG Group)
• Bosch Packaging Technology
• Körber Medipak Systems (Körber AG)
• Others

The Blister Packaging Machine Pharmaceutical Industry is segmented as follows:

By Machine Type

• Rotary Blister Machines
• Flat Blister Machines
• Thermoform Blister Machines
• Cold Form (Alu-Alu) Blister Machines

By Packaging Material

• PVC-Based Blisters
• PET-Based Blisters
• Aluminium Foil Blisters
• Composite Foil Blisters

By Filling Technology

• Thermoforming
• Cold Forming
• Heat Seal
• Glue Seal

By Application Type

• Solid Oral Dosage (Tablets, Capsules)
• Nutraceuticals (Vitamins, Supplements)
• Clinical Trial Blistering

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America